Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients.
about
Nitric oxide and hyperoxic acute lung injuryNrf2 expression is increased in peripheral blood mononuclear cells derived from mild-moderate ex-smoker COPD patients with persistent oxidative stressOxidative Stress in COPD: Sources, Markers, and Potential MechanismsDown-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.Role of nitric oxide synthases in elastase-induced emphysema.Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expressionIncreased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD.A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice.Elevated serum iron is a potent biomarker for spirometric resistance to cigarette smoke among Japanese males: the Takahata studyEnhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.Imaging pulmonary inducible nitric oxide synthase expression with PET.Heme oxygenase-1-mediated autophagy protects against pulmonary endothelial cell death and development of emphysema in cadmium-treated miceStrategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.Experimental progressive emphysema in BALB/cJ mice as a model for chronic alveolar destruction in humans.Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.Pulmonary biomarkers in chronic obstructive pulmonary disease.Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells?Expression of Nitric Oxide Synthase Isoenzyme in Lung Tissue of Smokers with and without Chronic Obstructive Pulmonary Disease.Alveolar macrophages as orchestrators of COPD.NRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction.Macrophage heterogeneity in respiratory diseases.Carbon monoxide in exhaled breath testing and therapeutics.Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.Identifying targets for COPD treatment through gene expression analyses.Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells.Gene-environment interaction effects on lung function- a genome-wide association study within the Framingham heart study.NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis.Exogenous neutrophil elastase enters bronchial epithelial cells and suppresses cigarette smoke extract-induced heme oxygenase-1 by cleaving sirtuin 1.Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.Biological monitoring of particulate matter accumulated in the lungs of urban asthmatic children in the Tel-Aviv area.The Unfolded Protein Response in Chronic Obstructive Pulmonary Disease.Carbon monoxide decreases the level of iNOS protein and active dimer in IL-1beta-stimulated hepatocytes.A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages.Attenuation of transforming growth factor-β-stimulated collagen production in fibroblasts by quercetin-induced heme oxygenase-1.Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease.The anti-inflammatory mechanism of heme oxygenase-1 induced by hemin in primary rat alveolar macrophages.Inducible nitric oxide synthase expression is increased in the alveolar compartment of asthmatic patients.Exhaled nitric oxide dynamics in asthmatic reactions induced by diisocyanates.Dysregulated Functions of Lung Macrophage Populations in COPD.Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women
P2860
Q28080203-3A3F29AC-FED4-4658-9AA0-179343EE7872Q28385626-4B4F34D1-0D93-4BE9-8235-24A54516B322Q29247910-D9105F2F-8029-4CCA-9EFF-F456D18F6ABCQ33345163-4E4C03DF-1112-4BF5-9676-826A40565FEDQ34024361-39C958B6-DDE9-48A0-8334-F3E07A270C0FQ34198929-16E4D8E8-316E-4751-B194-475886C972ECQ34882957-9B94A1E6-DCE1-4D34-AC1D-811684C5E53DQ34979542-82A23AB6-9D6D-4361-8807-9E24E81D0FAEQ34989644-89E15893-1E49-4BBB-BDBF-599CFEFE2D9BQ35537464-8CE2BDA2-02EE-42DB-8EC8-8DE81CA97530Q35849789-656ABBE3-0F7E-4E53-9131-48072857195EQ35916871-B857E179-B6EC-43D2-BF31-B0841FB7F7CFQ36036223-75755319-13DF-4152-BCB6-4C0DFAAA3FD9Q36122901-C92F8076-CB0C-49B8-A1F6-2A68938E6062Q36215313-9FA5B083-0EBC-4BBB-A290-9E678BB35179Q36429908-6937BFCA-96D2-434F-978C-F6C9CFFBDDCAQ36478157-4B4E5E45-0370-4B57-B459-E603651EC142Q36523159-7E052280-B851-46CB-A11A-48AF8ED32812Q36602291-74F60868-7DB3-42FE-A2AA-F3E495AAD68FQ36678635-84259020-92AA-4261-975E-F7B44E1738A0Q36692041-1A38680D-FEB0-4B63-B306-3160346FDECAQ36837240-64474180-75D1-4898-8788-C4682793B865Q36891496-8EDC637B-DA9F-41D1-966C-BC91A1F05179Q37070343-EC652D0D-2C19-4078-A5FD-E8BE08A87057Q37213580-8AD96CB7-BF48-4469-B306-2A89B90CA0C6Q37438727-36C6333E-AE29-4891-9CEF-CF4944796233Q37499698-7754E809-E9F8-44BE-A956-5E123C5350DCQ38701061-DA69B31F-0A9C-4284-B5AD-658968E56D65Q39804008-8AA6316B-DF25-4571-9B62-003C25707C34Q40216266-80F701DA-24C0-4080-9E63-AE1432E95530Q41043076-F309AD5D-29B3-4EEA-8F44-F1297CF9C9CFQ41930254-710A9C0A-D3B2-407F-86CB-8B18DDE0733FQ42113583-8B14F3BD-35CD-450B-9AAE-F28DB7D9247CQ42816044-42E480CD-8EDF-42ED-ABB5-1297842AB083Q45285612-8801FD93-8C02-42AD-8F43-DFA92496C339Q50520907-16EC682E-C63D-429C-9811-C1595E112E2AQ51453447-2F6CF7B2-05B1-4B74-9DF5-EBFF624D088CQ51469693-C5BBC48C-D048-4F62-87EA-F355D1514748Q55384969-614213B3-47C9-40CF-92C6-C0BF8C47D7B8Q56770457-EBDFF9F8-5F0A-46D0-B8BA-625F0FBB2600
P2860
Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Decreased haem oxygenase-1 and ...... lung of severe COPD patients.
@en
Decreased haem oxygenase-1 and ...... lung of severe COPD patients.
@nl
type
label
Decreased haem oxygenase-1 and ...... lung of severe COPD patients.
@en
Decreased haem oxygenase-1 and ...... lung of severe COPD patients.
@nl
prefLabel
Decreased haem oxygenase-1 and ...... lung of severe COPD patients.
@en
Decreased haem oxygenase-1 and ...... lung of severe COPD patients.
@nl
P2093
P50
P1476
Decreased haem oxygenase-1 and ...... e lung of severe COPD patients
@en
P2093
P304
P356
10.1183/09031936.03.00098203
P577
2003-06-01T00:00:00Z